Literature DB >> 3970361

Reduced anesthetic requirement after electrical stimulation of periaqueductal gray matter.

M F Roizen, P Newfield, E I Eger, Y Hosobuchi, J E Adams, S Lamb.   

Abstract

To determine whether electrical stimulation of the periaqueductal gray region decreases anesthetic requirement, the authors studied the effect of such stimulation on the MAC of halothane and 60% nitrous oxide in 33 patients. These patients, who were undergoing implantation of a radio-frequency-coupled receiver and connection of that receiver to electrodes previously implanted in the periaqueductal gray area, were assigned randomly to receive (n = 16) or not receive (n = 17) electrical stimulation 1 h before surgery. The mean value (+/- SEM) for the minimum alveolar concentration of halothane combined with 60% nitrous oxide was significantly less (P less than 0.001) for patients who were stimulated preoperatively (0.15 +/- 0.05%) than for those who were not (0.51 +/- 0.02%). The authors conclude that stimulation of the periaqueductal gray region decreases anesthetic requirements and believe that at least three mechanisms are possible: a nonspecific narcotic-like effect, a specific effect on a pain pathway, or an effect on specific neural pathways that affect anesthetic requirements secondary to changes in regional concentrations of neurotransmitters.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3970361     DOI: 10.1097/00000542-198502000-00004

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  2 in total

1.  Summary of the scientific literature for pain and anxiety control in dentistry. Journal literature, January-December, 1985.

Authors:  G L McAlister; C L Richardson
Journal:  Anesth Prog       Date:  1986 Sep-Oct

2.  The Mesencephalic Periaqueductal Gray, a Further Structure Involved in Breathing Failure Underlying Sudden Infant Death Syndrome.

Authors:  Anna M Lavezzi; Riffat Mehboob
Journal:  ASN Neuro       Date:  2021 Jan-Dec       Impact factor: 4.146

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.